Durvalumab,Carboplatin,Paclitaxel,Cisplatin,Gemcitabine,Pemetrexed,Pembrolizumab
Astrazeneca,merck
['caveat', 'aegean', 'kn671']
just starting to digest kn671 data from #asco2023.
always curious when there are control arm differences (cross trial caveats). aegean had numerically more patients with cn2 and ciiib, but 12% better efs in control arm at 24 months. treatment arms seem identical. thoughts? 
Thoracic surgeon expecting excellence. Cancer researcher. Patient advocate. #LungCancer #lcsm @lung_fund